Loading viewer...
earnings
Format: PDF earnings
Moderna presents its fourth quarter and full year 2022 financial results, covering revenue from COVID-19 vaccines, pipeline progress on RSV and personalized cancer vaccines, and 2023 guidance. The presentation includes business review, R&D updates, commercial strategy, and financial outlook from CEO Stéphane Bancel and leadership team.
conference
25 Pages
earnings
43 Pages
Prologis
Wajax Corporation 2016 Q3 Earnings Report
earningsearnings
40 Pages
Wajax Corporation